Evidence map›Paper›PMID 35081732›Full record

ArticleFuture oncology (London, England)2022

Efficacy and safety profile of COVID-19 vaccine in cancer patients: a prospective, multicenter cohort study.

Ayse Irem Yasin, Sabin Göktas Aydin, Bilge Sümbül, Lokman Koral, Melih Şimşek, Çağlayan Geredeli, Akın Öztürk, Perihan Perkin, Derya Demirtaş, Engin Erdemoglu and 19 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in Future oncology (London, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 3 pooled it
3.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 3 syntheses or guidelines pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Observational
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Observational
  19. Factors affecting the serologic response to SARS-CoV-2 vaccination in patients with solid tumors: A prospective study.Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy · 2022
    Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 19 institutions in 1 country.

Ayse Irem YasinBezmialem Vakif University, Department of Medical Oncology, Istanbul 34093, Turkey.ORCID 0000-0002-1528-8065
Sabin Göktas AydinMedipol University, Department of Medical Oncology, Istanbul 34214, Turkey.ORCID 0000-0002-0077-6971
Bilge SümbülBezmialem Vakif University, Department of Microbiology, Istanbul 34093, Turkey.
Lokman KoralCanakkale 18 March University, Department of Medical Oncology, Canakkale 17020 ,Turkey.
Melih ŞimşekBezmialem Vakif University, Department of Medical Oncology, Istanbul 34093, Turkey.ORCID 0000-0003-0633-8558
Çağlayan GeredeliOkmeydani Training and Research Hospital, Department of Medical Oncology, Istanbul 34384, Turkey.
Akın ÖztürkSureyyapasaChest Dıseases And Thoracıc Surgery Traınıng And Research Hospıtal, Department of Medical Oncology, Istanbul 34844, Turkey.
Perihan PerkinYildirim Beyazit University Yenimahalle Training and Research Hospital, Department of Medical Oncology, Ankara 06330, Turkey.
Derya DemirtaşAnkaraCity Hospital, Department of Medical Oncology, Ankara06800, Turkey.
Engin ErdemogluGöztepeMedeniyet University, Department of Medical Oncology, Istanbul 34000, Turkey.
İlhan HacıbekirogluSakarya University Medicine Faculty, Departmentof Medical Oncology, Sakarya 54050, Turkey.
Emre ÇakırSakarya University Medicine Faculty, Departmentof Medical Oncology, Sakarya 54050, Turkey.
Eda TanrıkuluHaydarpasa Training and Research Hospital, University of Health Sciences, Istanbul 34668, Turkey.
Ezgi ÇobanHaydarpasa Training and Research Hospital, University of Health Sciences, Istanbul 34668, Turkey.
Melike OzcelikMarmara University School of Medicine, Department of Medical Oncology, Istanbul 34722, Turkey.
Sinemis ÇelikIstanbul Oncology Hospital, Department of Medical Oncology, Istanbul 34846, Turkey.
Fatih TekerGaziantep University, Department of Medical Oncology, Gaziantep 27470, Turkey.
Asude AksoyFırat University Faculty of Medicine, Department of Medical Oncology, Elazıg 23119, Turkey.
Sedat T FıratErciyes University, Department of Medical Oncology, Kayseri 38039, Turkey.
Ömer TekinInönüUniversity, Department of Medical Oncology, Malatya 44280, Turkey.
Ziya KalkanDicleUniversity, Department of Medical Oncology, Diyarbakır 21200, Turkey.
Orhan TürkenMaltepeUniversity, Department of Medical Oncology, Istanbul 34844, Turkey.
Bala B OvenBahcesehir University School of Medicine, Department of Medical Oncology, Istanbul 34349, Turkey.
Faysal DaneAcıbadem University, Department of MedicalOncology, Istanbul 34758, Turkey.
Ahmet BiliciMedipol University, Department of Medical Oncology, Istanbul 34214, Turkey.
Abdurrahman IsıkdoganDicleUniversity, Department of Medical Oncology, Diyarbakır 21200, Turkey.
Mesut SekerBezmialem Vakif University, Department of Medical Oncology, Istanbul 34093, Turkey.
Hacı M TürkBezmialem Vakif University, Department of Medical Oncology, Istanbul 34093, Turkey.
Mahmut GümüşGöztepeMedeniyet University, Department of Medical Oncology, Istanbul 34000, Turkey.
Bezmiâlem Vakıf Üniversitesi · TRDicle University · TRHaydarpaşa Numune Eğitim ve Araştırma Hastanesi · TRIstanbul Medipol University · TRSakarya University · TRAcıbadem University · TRAnkara Yıldırım Beyazıt University · TRBahçeşehir University · TRCanakkale Onsekiz Mart Universitesi Tip Fakultesi Hastanesi · TRErciyes University · TRFırat University · TRGaziantep University · TRInonu University · TRIstanbul Eye Hospital · TRMaltepe University · TRMarmara University · TRMemorial Ankara Hospital · TROkmeydanı Eğitim ve Araştırma Hastanesi · TRYedikule Teaching Hospital · TR

Funding

Oncological Clinical Research Association (ONKAD)
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

VaccinationAdultAgedAged, 80 and overAntibodies, ViralCOVID-19COVID-19 VaccinesFemaleHumansMaleMiddle AgedNeoplasmsProspective StudiesSARS-CoV-2Vaccines, InactivatedYoung AdultAntibodies, ViralCOVID-19 VaccinesVaccines, InactivatedcancerchemotherapyCoronaVacCOVID-19COVID-19 vaccinesimmunotherapymalignancySARS-CoV-2

Identifiers

PMID35081732
PMCPMC8793921
OpenAlexW4210262630

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.